Phosphofructokinase-1 (PFK-1); allosterically activated by AMP and Fructose-2,6-bisphosphate, inhibited by ATP and Citrate.
Glucose-6-phosphatase deficiency; severe fasting hypoglycemia, lactic acidosis, hyperuricemia, hypertriglyceridemia, doll-like facies.
Both have cherry-red macula and neurodegeneration; Niemann-Pick (sphingomyelinase deficiency) adds hepatosplenomegaly and foam cells.
Alpha-galactosidase A deficiency accumulating ceramide trihexoside; acroparesthesias, angiokeratomas, hypohidrosis, renal/cardiac failure.
Most common urea cycle defect (X-linked recessive); hyperammonemia, elevated urinary orotic acid, low BUN, no megaloblastic anemia.
Porphobilinogen deaminase deficiency; 5 P's (Painful abdomen, Port-wine urine, Polyneuropathy, Psychological disturbances, Precipitated by CYP450 inducers).
X-linked HGPRT deficiency; impaired purine salvage causes hyperuricemia, gout, dystonia, intellectual disability, and self-mutilation.
Night blindness (nyctalopia), xerophthalmia, Bitot spots (keratin debris on conjunctiva), keratomalacia, and impaired measles immunity.
Bioenergetics, Glycolysis, Gluconeogenesis, TCA Cycle & Electron Transport
Cellular bioenergetics integrates cytosolic glycolysis, mitochondrial pyruvate oxidation, the tricarboxylic acid (TCA) cycle, gluconeogenesis, and the hexose monophosphate (HMP) shunt to maintain adenosine triphosphate (ATP) homeostasis and redox balance across fed and fasting states. In the absorptive state, pancreatic beta-cell insulin secretion activates protein phosphatase-1, dephosphorylating key regulatory enzymes and increasing hepatic PFK-2 activity to raise Fructose-2,6-bisphosphate, which potently drives phosphofructokinase-1 (PFK-1) and glycolytic flux. Conversely, during fasting, glucagon elevates intracellular cyclic AMP (cAMP) and protein kinase A (PKA), activating FBPase-2 to degrade Fructose-2,6-bisphosphate, inhibiting pyruvate kinase, and accelerating hepatic gluconeogenesis from lactate (Cori cycle), alanine (Cahill cycle), glycerol, and propionyl-CoA derived from odd-chain fatty acids.
Within the mitochondrial matrix, the pyruvate dehydrogenase (PDH) complex links glycolysis to the TCA cycle by converting pyruvate into acetyl-CoA; PDH requires five mandatory cofactors (Thiamine pyrophosphate B1, Lipoic acid, Coenzyme A B5, FAD B2, and NAD+ B3—remembered as Tender Loving Care For Nancy). Arsenic and mercury poison lipoic acid, causing Vomiting, rice-water stools, garlic breath, and lactic acidosis. In X-linked PDH deficiency, pyruvate shunts into lactate and alanine, producing neonatal neurologic defects and severe lactic acidosis; management requires a ketogenic diet enriched with lysine and leucine (the two purely ketogenic amino acids) to generate acetyl-CoA independent of PDH.
| Metabolic Pathway | Subcellular Site | Rate-Limiting Enzyme | Positive Regulators | Negative Regulators & Clinical Correlate |
|---|---|---|---|---|
| Glycolysis | Cytosol (all tissues) | Phosphofructokinase-1 (PFK-1) | AMP, Fructose-2,6-bisphosphate (insulin-driven) | ATP, Citrate, Glucagon (via FBPase-2 lowering F-2,6-BP) |
| Gluconeogenesis | Mitochondria & Cytosol / ER (liver, kidney) | Fructose-1,6-bisphosphatase (FBPase-1) | Citrate, Acetyl-CoA (activates pyruvate carboxylase), Glucagon | AMP, Fructose-2,6-bisphosphate; chronic ethanol excess depletes NAD+ and blocks gluconeogenesis |
| TCA (Krebs) Cycle | Mitochondrial matrix (Complex II on inner membrane) | Isocitrate dehydrogenase | ADP, Ca2+ (during skeletal muscle contraction) | ATP, NADH; requires B1, B2, B3, B5, lipoic acid at alpha-ketoglutarate dehydrogenase |
| HMP Shunt (Pentose Phosphate) | Cytosol (liver, adrenal cortex, RBCs, lactating mammary) | Glucose-6-phosphate dehydrogenase (G6PD) | NADP+ (oxidative stress demand) | NADPH; X-linked G6PD deficiency causes Heinz bodies and bite cells after sulfa, primaquine, dapsone, or fava beans |
| De Novo Fatty Acid vs. Beta-Oxidation | Synthesis: Cytosol | Beta-Oxidation: Mitochondria | Synthesis: Acetyl-CoA carboxylase (biotin) | Beta-Ox: CPT-1 | Insulin, Citrate activate synthesis | Malonyl-CoA inhibits Carnitine Palmitoyltransferase-1 (CPT-1) to prevent simultaneous synthesis and beta-oxidation |
Rate-Limiting Enzymes & Allosteric Regulation of Core Metabolic Pathways
Every metabolic pathway on USMLE and COMLEX examinations is anchored by a single irreversible rate-limiting enzyme. Glycolysis is governed by PFK-1; gluconeogenesis is governed by fructose-1,6-bisphosphatase (and requires four irreversible bypass enzymes: pyruvate carboxylase in mitochondria requiring biotin B7, PEP carboxykinase in cytosol, fructose-1,6-bisphosphatase in cytosol, and glucose-6-phosphatase in the endoplasmic reticulum of liver and kidney—absent in skeletal muscle). The TCA cycle is regulated by isocitrate dehydrogenase (activated by ADP, inhibited by ATP and NADH), while the HMP shunt (pentose phosphate pathway) is regulated by glucose-6-phosphate dehydrogenase (G6PD), which generates NADPH for glutathione reduction, reductive biosynthesis of fatty acids and steroids, cytochrome P450 metabolism, and the phagocytic respiratory burst.
Electron Transport Chain (ETC) Complexes, Inhibitors & Uncouplers
Oxidative phosphorylation across the inner mitochondrial membrane couples electron transfer through Complexes I–IV to proton pumping into the intermembrane space, driving Complex V (ATP synthase). Complex I (NADH dehydrogenase) is inhibited by rotenone, MPP+, and barbiturates; Complex II (succinate dehydrogenase, the only TCA enzyme embedded in the inner mitochondrial membrane, passing electrons via FADH2 without pumping protons) is unobstructed by rotenone; Complex III (cytochrome bc1) is inhibited by antimycin A; and Complex IV (cytochrome c oxidase) is inhibited by cyanide, carbon monoxide, andazide. Cyanide binds ferric iron (Fe3+) in Complex IV, halting electron transport and producing bright red venous blood with severe lactic acidosis (treated with hydroxocobalamin or nitrites plus sodium thiosulfate). Uncouplers such as 2,4-dinitrophenol, toxic salicylate (aspirin) overdose, and thermogenin (UCP-1) in brown adipose tissue permeabilize the inner mitochondrial membrane to protons, collapsing the proton gradient so oxygen consumption and heat production surge while ATP synthesis plummets.
Glycogen Storage Diseases (Types I–V) & Galactose/Fructose Disorders
Glycogen synthesis (regulated by glycogen synthase) and glycogenolysis (regulated by glycogen phosphorylase, requiring pyridoxal phosphate B6 as a cofactor) buffer blood glucose between meals and supply rapid ATP during skeletal muscle contraction. Glycogen Storage Diseases (GSDs) are autosomal recessive enzymatic defects categorized into hepatic phenotypes (presenting with fasting hypoglycemia and hepatomegaly, exemplified by Type I Von Gierke and Type III Cori) and myopathic/cardiomyopathic phenotypes (exemplified by Type II Pompe and Type V McArdle). Differentiating the major GSDs on board vignettes relies on fasting blood glucose levels, blood lactate, muscle versus liver involvement, and debranching limit dextrin accumulation.
Monosaccharide metabolism defects of fructose and galactose follow a parallel two-step enzymatic pattern: a benign kinase deficiency that causes asymptomatic sugar accumulation in blood and urine (positive copper reduction test for reducing sugars) versus a severe second-step transferase/aldolase deficiency that traps phosphorylated intermediates intracellularly, depleting inorganic phosphate and ATP while causing hepatomegaly, jaundice, cirrhosis, and life-threatening hypoglycemia.
| Disorder | Deficient Enzyme | Accumulated Substrate | Hallmark Clinical Features | Diagnostic & Therapeutic Pearls |
|---|---|---|---|---|
| Von Gierke Disease (GSD Type I) | Glucose-6-phosphatase (Ia) or G6P translocase (Ib) | Glycogen and Glucose-6-phosphate in liver/kidney | Severe fasting hypoglycemia, hepatorenomegaly, lactic acidosis, hyperuricemia, hypertriglyceridemia | No rise in blood glucose after glucagon administration; treat with uncooked cornstarch, avoid fructose/galactose |
| Pompe Disease (GSD Type II) | Lysosomal acid alpha-1,4-glucosidase (acid maltase) | Lysosomal glycogen in myocardium, skeletal muscle, liver | Infantile hypertrophic cardiomyopathy, macroglossia, hypotonia (floppy baby), normal blood glucose | PAS-positive glycogen vacuoles in lysosomes; enzyme replacement therapy with alglucosidase alfa |
| Cori Disease (GSD Type III) | Debranching enzyme (alpha-1,6-glucosidase) | Cytosolic limit dextrin-like structures (short outer branches) | Hepatomegaly, mild fasting hypoglycemia, myopathy/cardiomyopathy, normal blood lactate and uric acid | Gluconeogenesis remains intact (unlike Von Gierke), explaining normal serum lactate |
| McArdle Disease (GSD Type V) | Skeletal muscle glycogen phosphorylase (myophosphorylase) | Morphologically normal glycogen in skeletal muscle | Exercise intolerance, painful cramps, myoglobinuria (red urine), flat venous lactate curve, second-wind phenomenon | Normal liver glycogenolysis and fasting blood glucose; supplement with pre-exercise sucrose |
| Classic Galactosemia vs. Hereditary Fructose Intolerance | GALT (Galactosemia) vs. Aldolase B (HFI) | Galactose-1-P & Galactitol vs. Fructose-1-P | Galactosemia: cataracts, hepatomegaly, neonatal E. coli sepsis | HFI: post-fruit hypoglycemia, vomiting, cirrhosis | Galactosemia: soy-based lactose-free formula | HFI: eliminate dietary fructose, sucrose, and sorbitol |
Differentiating Types I, II, III & V Glycogen Storage Diseases
Type I (Von Gierke disease) results from glucose-6-phosphatase (GSD Ia) or glucose-6-phosphate translocase (GSD Ib, which adds neutropenia) deficiency in the liver and kidney; patients present at 3–4 months of age with severe fasting hypoglycemia, hepatorenomegaly, doll-like facies, severe lactic acidosis, hypertriglyceridemia, and hyperuricemia (gout), managed with frequent oral cornstarch and avoidance of fructose and galactose. Type II (Pompe disease) is the only lysosomal GSD, caused by acid alpha-1,4-glucosidase (acid maltase) deficiency; it presents in infancy with hypertrophic cardiomyopathy, macroglossia, profound hypotonia, and early death (“Pompe trashes the Pump”), with normal blood glucose. Type III (Cori disease) is caused by debranching enzyme (alpha-1,6-glucosidase) deficiency, leading to accumulation of cytosolic limit dextrin-like structures, milder fasting hypoglycemia and hepatomegaly, and normal blood lactate because gluconeogenesis remains intact. Type V (McArdle disease) results from skeletal muscle glycogen phosphorylase (myophosphorylase) deficiency; adolescents present with painful muscle cramps, rhabdomyolysis, myoglobinuria, and a flat venous lactate curve during ischemic forearm exercise, coupled with a characteristic “second-wind” phenomenon after 10 minutes as muscular blood flow delivers free fatty acids.
Fructose & Galactose Metabolic Defects (Aldolase B vs. GALT)
Essential fructosuria (fructokinase deficiency) is an asymptomatic, benign condition in which fructose spills into the urine. In contrast, Hereditary Fructose Intolerance (aldolase B deficiency) manifests after weaning when infants first ingest fruit, juice, or honey (sucrose = glucose + fructose); intracellular trapping of fructose-1-phosphate depletes ATP and inorganic phosphate, inhibiting both glycogenolysis and gluconeogenesis to cause severe hypoglycemia, vomiting, jaundice, cirrhosis, and proximal renal tubular acidosis (Fanconi syndrome). Similarly, galactokinase deficiency causes mild pediatric cataracts (due to aldose reductase converting galactose to galactitol in the lens) and failure to track objects or develop a social smile, whereas Classic Galactosemia (galactose-1-phosphate uridyltransferase [GALT] deficiency) presents in the first days of life upon initiating breast milk or lactose-containing formula with vomiting, hepatomegaly, jaundice, bilateral oil-drop cataracts, intellectual disability, and fatal neonatal Escherichia coli sepsis; immediate discontinuation of all milk and lactose products (switching to soy formula) is mandatory.
Lysosomal Storage Diseases: Sphingolipidoses & Mucopolysaccharidoses
Lysosomal storage diseases result from congenital deficiencies of acid hydrolases required to degrade complex sphingolipids or glycosaminoglycans (mucopolysaccharides). All lysosomal storage disorders are inherited in an autosomal recessive pattern except for two X-linked recessive conditions: Fabry disease (sphingolipidosis) and Hunter syndrome (mucopolysaccharidosis type II). Because neurons and reticuloendothelial macrophages have high membrane lipid turnover, enzymatic blocks lead to progressive intralysosomal substrate accumulation, manifesting with characteristic ophthalmologic signs (cherry-red macula versus corneal clouding), hepatosplenomegaly, peripheral neuropathy, and distinctive histopathologic inclusions.
In addition to single-hydrolase defects, I-cell disease (mucolipidosis type II) stems from failure of the Golgi apparatus N-acetylglucosaminyl-1-phosphotransferase to phosphorylate mannose residues into mannose-6-phosphate on lysosomal enzymes; consequently, hydrolases are secreted extracellularly into the plasma rather than trafficked to lysosomes, causing coarse facial features, corneal clouding, gingival hyperplasia, claw-hand deformities, kyphoscoliosis, and PAS-positive intracytoplasmic inclusions within fibroblasts.
| Disorder & Inheritance | Deficient Enzyme | Accumulated Substrate | Pathognomonic Histopathology / Exam Sign | Key Clinical Differentiators |
|---|---|---|---|---|
| Tay-Sachs Disease (AR) | Hexosaminidase A | GM2 ganglioside | Cherry-red macula, onion-skin lysosomes on EM | Hyperacusis (startle reflex), neurodegeneration, NO hepatosplenomegaly |
| Niemann-Pick Disease (AR) | Sphingomyelinase | Sphingomyelin | Cherry-red macula, lipid-laden foam cells, zebra bodies | Progressive neurodegeneration WITH prominent hepatosplenomegaly |
| Gaucher Disease (AR) | Beta-glucocerebrosidase | Glucocerebroside | Gaucher cells (macrophages with crumpled tissue-paper cytoplasm) | Most common LSD; hepatosplenomegaly, pancytopenia, bone crises, avascular necrosis of femoral head |
| Fabry Disease (X-Linked Recessive) | Alpha-galactosidase A | Ceramide trihexoside (globotriaosylceramide) | Angiokeratomas (bathing-trunk), Maltese-cross urinary lipids | Early triad: episodic acroparesthesias, angiokeratomas, hypohidrosis; late renal and cardiac failure |
| Hurler (AR) vs. Hunter (X-Linked) | Alpha-L-iduronidase vs. Iduronate-2-sulfatase | Heparan sulfate & Dermatan sulfate | Hurler: Corneal clouding | Hunter: Clear corneas | Both feature coarse facies and hepatosplenomegaly; Hunter adds aggressive behavior without corneal clouding |
Sphingolipidoses: Tay-Sachs, Niemann-Pick, Gaucher, Fabry, Krabbe & Metachromatic Leukodystrophy
Gaucher disease is the most common lysosomal storage disorder, caused by beta-glucocerebrosidase (glucocerebrosidase) deficiency and accumulation of glucocerebroside; patients present with hepatosplenomegaly, pancytopenia, avascular necrosis of the femur, bone crises, and hallmark Gaucher cells (lipid-laden macrophages resembling crumpled tissue paper). Tay-Sachs disease (hexosaminidase A deficiency, GM2 ganglioside accumulation) and Niemann-Pick disease (sphingomyelinase deficiency, sphingomyelin accumulation) both present in Ashkenazi Jewish infants with progressive neurodegeneration and a macular cherry-red spot; however, Tay-Sachs has no hepatosplenomegaly and shows onion-skin lysosomes on electron microscopy, whereas Niemann-Pick features prominent hepatosplenomegaly and lipid-laden foam cells (zebra bodies). Fabry disease (X-linked alpha-galactosidase A deficiency, ceramide trihexoside accumulation) presents in childhood/adolescence with episodic burning neuropathic pain in the hands and feet (acroparesthesias), hypohidrosis, and clusters of reddish-purple angiokeratomas in the bathing-trunk distribution, progressing in adulthood to proteinuric renal failure and restrictive/hypertrophic cardiomyopathy. Krabbe disease (galactocerebrosidase deficiency) causes optic atrophy, peripheral neuropathy, developmental regression, and multinucleated globoid cells, while Metachromatic leukodystrophy (arylsulfatase A deficiency) causes cerebroside sulfate accumulation with central and peripheral demyelination, ataxia, and dementia.
Mucopolysaccharidoses: Hurler Syndrome (MPS I) vs. Hunter Syndrome (MPS II)
Mucopolysaccharidoses impair the degradation of heparan sulfate and dermatan sulfate. Hurler syndrome (MPS I) is an autosomal recessive deficiency of alpha-L-iduronidase presenting with developmental delay, gargoylism (coarse facial features, frontal bossing), airway obstruction, hepatosplenomegaly, dysostosis multiplex, and prominent corneal clouding. Hunter syndrome (MPS II) is an X-linked recessive deficiency of iduronate-2-sulfatase presenting with milder developmental delay, aggressive behavioral hyperactivity, hepatosplenomegaly, and carpal tunnel syndrome, with no corneal clouding (remembered as “Hunters see clearly to aim for the X”).
Amino Acidopathies (PKU, MSUD, Homocystinuria, Alkaptonuria) & Urea Cycle Defects
Inborn errors of amino acid catabolism and nitrogen disposal present in the neonatal or early pediatric period with characteristic urine odors, neurodevelopmental regression, or thromboembolic/connective tissue complications. Newborn heel-stick tandem mass spectrometry screens for treatable amino acidopathies such as phenylketonuria (PKU), maple syrup urine disease (MSUD), and homocystinuria so dietary restriction and cofactor supplementation can prevent irreversible central nervous system injury.
Protein catabolism generates toxic ammonia (NH3), which crosses the blood-brain barrier and depletes alpha-ketoglutarate and glutamate while increasing glutamine inside astrocytes, triggering cerebral edema, asterixis, lethargy, vomiting, and hyperventilatory respiratory alkalosis. The hepatic urea cycle converts ammonia and bicarbonate into nontoxic, water-soluble urea via five sequential enzymes spanning the mitochondria (carbamoyl phosphate synthetase I [CPS-I] and ornithine transcarbamylase [OTC]) and cytosol (argininosuccinate synthetase, argininosuccinate lyase, and arginase).
| Metabolic Disorder | Deficient Enzyme / Transporter | Biochemical Signature | Clinical Presentation | Targeted Management |
|---|---|---|---|---|
| Phenylketonuria (PKU) | Phenylalanine hydroxylase (classic) or BH4 cofactor regeneration | Elevated phenylalanine, phenylacetate, phenyllactate; tyrosine becomes essential | Intellectual disability, microcephaly, seizures, eczema, fair complexion, musty/mousy odor | Dietary phenylalanine restriction (avoid aspartame), tyrosine supplementation; sapropterin (BH4) if cofactor-deficient |
| Maple Syrup Urine Disease | Branched-chain alpha-ketoacid dehydrogenase (B1, B2, B3, B5, lipoic acid) | Elevated Leucine, Isoleucine, Valine and alpha-ketoacids in blood/urine | Neonatal encephalopathy, lethargy, dystonia, seizures, sweet burnt-sugar urine odor | Restrict dietary isoleucine, leucine, valine; trial high-dose thiamine (Vitamin B1) |
| Homocystinuria vs. Marfan | Cystathionine synthase (B6) or Methionine synthase (B12) | Markedly elevated plasma/urine homocysteine and methionine | Marfanoid habitus, downward/inward lens subluxation, intellectual disability, premature DVT/stroke/MI | Pyridoxine (B6), folate, B12, betaine, and dietary methionine restriction with cysteine supplementation |
| OTC Deficiency (X-Linked) | Ornithine transcarbamylase (mitochondrial) | Hyperammonemia, low BUN, elevated urinary orotic acid, normal RBC MCV | Male neonate at 24–72 hours after protein feed: vomiting, tachypnea, lethargy, cerebral edema, coma | Stop protein intake, IV dextrose, ammonia scavengers (sodium phenylbutyrate/benzoate), arginine supplementation |
| Cystinuria (AR) | Renal PCT dibasic transporter (COLa: Cystine, Ornithine, Lysine, Arginine) | Urinary excretion of dibasic amino acids; positive cyanide-nitroprusside test | Recurrent radiopaque nephrolithiasis with hexagonal cystine crystals on urinalysis | Aggressive hydration, urinary alkalinization (potassium citrate, acetazolamide), tiopronin or D-penicillamine |
PKU, Maple Syrup Urine Disease, Alkaptonuria, Homocystinuria & Cystinuria
Phenylketonuria (PKU) stems from autosomal recessive deficiency of phenylalanine hydroxylase (or its cofactor tetrahydrobiopterin [BH4], regenerated by dihydropteridine reductase), preventing conversion of phenylalanine to tyrosine (making tyrosine an essential dietary amino acid). Accumulated phenylketones produce a musty body odor, intellectual disability, microcephaly, seizures, and fair skin/eczema (due to competitive inhibition of tyrosinase); BH4 deficiency additionally depletes serotonin and catecholamines, requiring BH4 and neurotransmitter precursor supplementation alongside phenylalanine restriction (including avoidance of aspartame). Maple Syrup Urine Disease (MSUD) results from deficiency of the branched-chain alpha-ketoacid dehydrogenase complex (requiring B1, B2, B3, B5, and lipoic acid), blocking degradation of Isoleucine, Leucine, and Valine; neonates develop vomiting, poor feeding, lethargy, dystonia, and burnt-sugar/maple-syrup urine within days of birth (treated with dietary restriction of branched-chain amino acids and high-dose thiamine for thiamine-responsive variants). Alkaptonuria (homogentisate oxidase deficiency) causes benign dark/black urine upon standing, bluish-black ochronotic pigmentation of sclerae and ear cartilage, and debilitating large-joint ochronotic arthropathy. Homocystinuria (most commonly cystathionine synthase deficiency; treated with pyridoxine B6, folate, B12, and cysteine supplementation) presents with marfanoid habitus, downward-and-inward (inferomedial) ectopia lentis, intellectual disability, osteoporosis, and premature arterial/venous thromboembolism. Cystinuria is a defect in the PCT dibasic amino acid transporter (COAL: Cystine, Ornithine, Arginine, Lysine) causing recurrent radiopaque hexagonal cystine kidney stones that precipitate in acidic urine (diagnosed via positive urinary cyanide-nitroprusside test and treated with urinary alkalinization using potassium citrate, high fluid intake, and tiopronin/penicillamine).
Urea Cycle Disorders: Ornithine Transcarbamylase (OTC) vs. CPS-I Deficiency
Rate-limiting Carbamoyl phosphate synthetase I (CPS-I) requires N-acetylglutamate as an obligate allosteric activator. When hyperammonemia presents in a neonate (tachypnea, lethargy, vomiting, cerebral edema, and low BUN), measuring urinary orotic acid differentiates the two mitochondrial urea cycle defects: CPS-I deficiency (or N-acetylglutamate synthase deficiency) yields low carbamoyl phosphate and therefore normal/low urinary orotic acid, whereas X-linked Ornithine transcarbamylase (OTC) deficiency (the most common urea cycle disorder) causes mitochondrial carbamoyl phosphate to spill into the cytosolic pyrimidine synthesis pathway, producing markedly elevated urinary orotic acid with hyperammonemia (distinguished from Orotic Aciduria [UMP synthase deficiency], which presents with elevated orotic acid, megaloblastic anemia unresponsive to B12/folate, and normal ammonia). Acute hyperammonemia is treated with protein restriction, intravenous sodium benzoate or sodium phenylbutyrate (which scavenge glycine and glutamine for renal excretion), and arginine supplementation.
Heme Synthesis, Porphyrias, Lead Poisoning & Purine Salvage Defects
Heme biosynthesis spans the mitochondria and cytosol in erythroid precursors (85%) and hepatocytes (15%), beginning with the rate-limiting mitochondrial condensation of glycine and succinyl-CoA by aminolevulinic acid (ALA) synthase, an enzyme strictly dependent on pyridoxal phosphate (Vitamin B6). Heme exerts negative feedback on hepatic ALA synthase transcription, whereas CYP450-inducing medications (barbiturates, phenytoin, carbamazepine, rifampin, griseofulvin, sulfonamides), alcohol, and fasting deplete intracellular heme pools and powerfully upregulate ALA synthase—precipitating acute neurovisceral attacks in hepatic porphyrias.
Purine nucleotides (adenine and guanine) are synthesized de novo from ribose-5-phosphate (via PRPP synthetase and rate-limiting glutamine-PRPP amidotransferase) or recycled via the energy-saving purine salvage pathway, where hypoxanthine-guanine phosphoribosyltransferase (HGPRT) converts hypoxanthine to IMP and guanine to GMP, while adenine phosphoribosyltransferase (APRT) salvages adenine. Excess purines are catabolized by xanthine oxidase into uric acid.
| Condition | Deficient / Inhibited Enzyme | Accumulated Metabolites | Classic Clinical Presentation | Definitive Treatment |
|---|---|---|---|---|
| Lead Poisoning | ALA dehydratase & Ferrochelatase | Delta-ALA (urine/plasma) & Protoporphyrin IX (RBCs) | Microcytic anemia with basophilic stippling, abdominal colic, wrist/foot drop, gingival Burton lines, metaphyseal lead lines | Remove exposure; chelation with Succimer (DMSA) in kids, EDTA + Dimercaprol (BAL) for severe lead encephalopathy |
| Acute Intermittent Porphyria (AD) | Porphobilinogen (PBG) deaminase | Delta-ALA & Porphobilinogen (PBG) in urine | 5 P's: Painful abdomen, Port-wine urine, Polyneuropathy, Psychological symptoms, Precipitated by CYP450 inducers; NO rash | IV Hemin and IV dextrose (represses hepatic ALA synthase); avoid barbiturates, phenytoin, sulfonamides |
| Porphyria Cutanea Tarda | Uroporphyrinogen decarboxylase | Uroporphyrin (tea-colored urine, pink fluorescence) | Blistering cutaneous photosensitivity on dorsal hands, skin fragility, hypertrichosis; linked to Hepatitis C and iron overload | Sun avoidance, therapeutic phlebotomy to reduce hepatic iron, or low-dose hydroxychloroquine |
| Lesch-Nyhan Syndrome (X-Linked) | HGPRT (purine salvage) | Uric acid, hypoxanthine, guanine, PRPP | HGPRT = Hyperuricemia, Gout, Pissed off (aggression/self-mutilation of lips and fingers), Red/orange crystals in diaper, Tense muscles (dystonia) | Allopurinol or febuxostat to lower uric acid |
| Hereditary Orotic Aciduria (AR) | UMP synthase (bifunctional) | Orotic acid in urine (NORMAL blood ammonia) | Pediatric megaloblastic anemia refractory to B12/folate, failure to thrive, orange crystalluria | Oral uridine triacetate / uridine supplementation (bypasses UMP synthase) |
Lead Poisoning vs. Acute Intermittent Porphyria vs. Porphyria Cutanea Tarda
Lead poisoning inhibits two sulfhydryl-containing heme enzymes—cytosolic ALA dehydratase and mitochondrial ferrochelatase—leading to accumulation of delta-ALA and protoporphyrin IX, microcytic hypochromic sideroblastic anemia with coarse basophilic stippling (due to inhibition of ribonuclease), Burton lines on gingivae, metaphyseal lead lines on radiographs, wrist/foot drop, and abdominal colic. Acute Intermittent Porphyria (AIP) is an autosomal dominant deficiency of porphobilinogen (PBG) deaminase (hydroxymethylbilane synthase); accumulated ALA and PBG cause episodic severe abdominal pain (without peritonitis), autonomic tachycardia/hypertension, peripheral motor neuropathy, psychosis, and urine that turns dark port-wine red upon standing in light, with zero cutaneous photosensitivity. Treatment of acute AIP attacks requires intravenous hemin and high-dose IV glucose to transcriptionally repress hepatic ALA synthase. Conversely, Porphyria Cutanea Tarda (PCT) is the most common porphyria, caused by deficiency of uroporphyrinogen decarboxylase; uroporphyrin accumulates (producing tea-colored urine with coral-pink Wood lamp fluorescence) and causes chronic blistering cutaneous photosensitivity on sun-exposed dorsal hands and face with hypertrichosis, strongly associated with Hepatitis C, HIV, alcohol use, and hereditary hemochromatosis (treated with therapeutic phlebotomy or low-dose hydroxychloroquine).
Purine Salvage & Pyrimidine Synthesis: Lesch-Nyhan, ADA-SCID & Orotic Aciduria
Lesch-Nyhan syndrome is an X-linked recessive absence of HGPRT; failure to salvage hypoxanthine and guanine shunts PRPP and purine bases into xanthine oxidase catabolism, producing orange uric acid crystals in the diaper, juvenile gouty arthritis, urate nephropathy, choreoathetosis/dystonia, intellectual disability, and compulsive self-mutilating lip and finger biting (managed with allopurinol or febuxostat for hyperuricemia). Adenosine deaminase (ADA) deficiency is an autosomal recessive purine degradation defect in which excess dATP allosterically inhibits ribonucleotide reductase, arresting DNA synthesis in T, B, and NK lymphocytes and causing Severe Combined Immunodeficiency (SCID). In the de novo pyrimidine synthesis pathway, Hereditary Orotic Aciduria results from autosomal recessive deficiency of UMP synthase, presenting in children with urinary orotic acid crystalluria, failure to thrive, and megaloblastic anemia unresponsive to vitamin B12 or folate, with completely normal blood ammonia; treatment is oral uridine supplementation, which bypasses the enzymatic block and restores UTP feedback inhibition on carbamoyl phosphate synthetase II.
Water- & Fat-Soluble Vitamins, Trace Minerals & Collagen/Elastin Synthesis
Micronutrient cofactors and trace minerals govern rate-limiting enzymatic reactions across energy metabolism, hematopoiesis, coagulation, and extracellular matrix cross-linking. Fat-soluble vitamins (A, D, E, K) require pancreatic lipase, bile salts, and intact terminal ileal enterocytes for micellar absorption—placing patients with cystic fibrosis, celiac disease, Crohn disease, primary biliary cholangitis, or bariatric Roux-en-Y gastric bypass at high risk for combined fat-soluble deficiencies—whereas water-soluble vitamins (B-complex and Vitamin C) leach rapidly during malnutrition or hemodialysis, with the exception of Vitamin B12 (cobalamin), which maintains a 3–4 year hepatic storage reserve.
Extracellular matrix integrity depends on triple-helical collagen (Gly-X-Y repeats, where X and Y are proline or lysine) and cross-linked elastin. Rough endoplasmic reticulum pro-alpha chains undergo vitamin C-dependent hydroxylation of proline and lysine residues (requiring Fe2+ and alpha-ketoglutarate), glycosylation, triple-helix assembly (defective in Osteogenesis Imperfecta), exocytosis, procollagen peptidase cleavage (defective in Ehlers-Danlos syndrome), and extracellular covalent cross-linking by copper-dependent lysyl oxidase (defective in X-linked Menkes disease).
| Vitamin / Structural Protein | Biochemical Function / Cofactor Role | Deficiency / Mutation Syndrome | Hallmark Clinical Signs | Board Diagnostic & Therapeutic Pearl |
|---|---|---|---|---|
| Vitamin A (Retinol / Retinoic Acid) | Visual pigments (rhodopsin), epithelial differentiation, PML-RARA myeloid differentiation | Vitamin A Deficiency vs. Hypervitaminosis A | Deficiency: Nyctalopia, xerophthalmia, Bitot spots, keratomalacia | Toxicity: Pseudotumor cerebri, teratogenicity | All-trans retinoic acid (ATRA) treats M3 Acute Promyelocytic Leukemia; Vitamin A supplementation reduces measles mortality |
| Vitamin B3 (Niacin / NAD+ / NADP+) | Redox cofactor; synthesized endogenously from Tryptophan (requires B2 and B6) | Pellagra (3 D's: Diarrhea, Dermatitis, Dementia) | Photosensitive hyperpigmented Casal necklace rash, glossitis, confusion | Caused by Hartnup disease (neutral amino acid transporter defect), carcinoid syndrome (serotonin steals TRP), or isoniazid |
| Vitamin C (Ascorbic Acid) | Hydroxylation of proline/lysine in collagen synthesis; reduces Fe3+ to Fe2+ for GI absorption; dopamine beta-hydroxylase cofactor | Scurvy (defective collagen triple-helix cross-linking) | Swollen bleeding gums, perifollicular petechiae, corkscrew hairs, hemarthrosis, poor wound healing | Tea-and-toast diet in elderly or infants fed exclusively evaporated cow's milk; normal PT/PTT and platelet count |
| Type I, III & IV Collagen Defects | Type I (Bone/Skin/Tendon), Type III (Blood vessels/Uterus), Type IV (Basement membranes) | Osteogenesis Imperfecta (I), Vascular EDS (III), Alport Syndrome (IV) | OI: Blue sclerae, fractures, hearing loss | Vascular EDS: Berry aneurysm/bowel rupture | Alport: Nephritis + deafness + lenticonus | Distinguish OI from child abuse by blue sclerae, dentinogenesis imperfecta, family history, and generalized osteopenia |
| Fibrillin-1 (FBN1) vs. Lysyl Oxidase (ATP7A) | FBN1: Elastin microfibril scaffold | ATP7A: Copper transport for lysyl oxidase collagen cross-linking | Marfan Syndrome (AD FBN1) vs. Menkes Disease (X-linked ATP7A) | Marfan: Arachnodactyly, superotemporal lens dislocation, aortic root dilation | Menkes: Brittle kinky hair, hypotonia, aneurysms | Compare lens dislocation: Marfan is Up-and-Out (superotemporal); Homocystinuria is Down-and-In (inferomedial) |
Fat-Soluble (A, D, E, K) & Water-Soluble (B1–B12, C) Vitamin Syndromes
Vitamin A (retinol) deficiency causes nyctalopia (night blindness), dry conjunctivae (xerophthalmia), Bitot spots (foamy keratin debris on the bulbar conjunctiva), keratomalacia, and immunosuppression, whereas Vitamin A toxicity causes pseudotumor cerebri (idiopathic intracranial hypertension), alopecia, hepatotoxicity, and severe neural crest craniofacial/cardiac teratogenicity (requiring two forms of contraception before prescribing isotretinoin). Vitamin B1 (thiamine) deficiency impairs PDH, alpha-ketoglutarate dehydrogenase, transketolase, and branched-chain ketoacid dehydrogenase, causing Wernicke-Korsakoff syndrome and wet/dry beriberi. Vitamin B2 (riboflavin) deficiency causes cheilosis, angular stomatitis, glossitis, and corneal vascularization (the 2 C's). Vitamin B3 (niacin) deficiency (resulting from corn-based diets, isoniazid therapy, Hartnup disease [defective renal/GI neutral amino acid TRP transporter], or malignant carcinoid syndrome) causes Pellagra (Diarrhea, Dermatitis with a C3/C4 Casal necklace, Dementia). Vitamin B6 (pyridoxine) deficiency (induced by isoniazid or oral contraceptives) causes convulsions, hyperirritability, peripheral neuropathy, and sideroblastic anemia. Vitamin C (ascorbic acid) deficiency impairs prolyl/lysyl hydroxylase in collagen synthesis, causing Scurvy (swollen bleeding gums, perifollicular hemorrhages, corkscrew hairs, subperiosteal hematomas, and poor wound healing).
Collagen (Osteogenesis Imperfecta, Ehlers-Danlos, Alport) & Elastin (Marfan) Disorders
Osteogenesis Imperfecta is an autosomal dominant mutation in COL1A1/COL1A2 impairing Type I collagen triple-helix formation; patients present with multiple fractures after minimal trauma (frequently mistaken for non-accidental child abuse), blue sclerae (translucent choroidal veins), conductive hearing loss (otosclerosis-like ossicular fractures), and opalescent dentinogenesis imperfecta. Ehlers-Danlos syndrome encompasses hypermobile (Type V collagen), classical (Type V collagen with hyperextensible skin and atrophic cigarette-paper scars), and life-threatening vascular type (Type III reticular collagen deficiency causing spontaneous aortic dissection, berry aneurysm rupture, and hollow-organ bowel/uterine perforation). Alport syndrome is an X-linked dominant mutation in Type IV basement membrane collagen (COL4A5), presenting with hematuria/glomerulonephritis, sensorineural hearing loss, and anterior lenticonus (“Can't see, can't pee, can't hear a bee”) with characteristic basket-weave splitting of the glomerular basement membrane on electron microscopy. Marfan syndrome is an autosomal dominant mutation in the FBN1 gene encoding fibrillin-1 (which forms the microfibrillar scaffold for elastin), presenting with tall stature, arachnodactyly (positive wrist and thumb signs), pectus excavatum/carinatum, upward-and-outward (superotemporal) ectopia lentis, mitral valve prolapse, and cystic medial necrosis of the ascending aorta predisposing to Stanford Type A aortic dissection.
Osteopathic Considerations in Hepatic, Splenic & Metabolic Storage Disorders
- Never confuse Tay-Sachs and Niemann-Pick: both present in infants with progressive neurodegeneration and a cherry-red macula, but Niemann-Pick (sphingomyelinase deficiency) has prominent hepatosplenomegaly and foam cells, whereas Tay-Sachs (hexosaminidase A deficiency) has NO hepatosplenomegaly.
- In hyperammonemia with elevated urinary orotic acid, always check for megaloblastic anemia: OTC deficiency presents with hyperammonemia, elevated orotic acid, and NORMAL MCV, whereas Hereditary Orotic Aciduria (UMP synthase deficiency) presents with megaloblastic anemia (unresponsive to B12/folate) and NORMAL ammonia.
- Never administer CYP450-inducing anticonvulsants (phenytoin, carbamazepine, barbiturates) to a patient with Acute Intermittent Porphyria; these drugs deplete hepatic heme and upregulate ALA synthase, triggering fatal neurovisceral paralysis—treat seizures with levetiracetam or gabapentin and administer IV hemin plus dextrose.
- Distinguish lens subluxation direction on board vignettes: Marfan syndrome (FBN1 fibrillin-1 mutation) causes upward-and-outward (superotemporal) ectopia lentis with aortic root cystic medial necrosis, whereas Homocystinuria (cystathionine synthase deficiency) causes downward-and-inward (inferomedial) ectopia lentis with intellectual disability and premature DVT/stroke.
- In a child presenting with multiple fractures in various stages of healing, always differentiate Osteogenesis Imperfecta (COL1A1/COL1A2 mutation causing blue sclerae, conductive hearing loss, and dentinogenesis imperfecta) from non-accidental trauma (posterior rib fractures, metaphyseal corner fractures, retinal hemorrhages, normal sclerae).
- When treating combined Vitamin B12 and folate deficiency or malnourished alcohol-use disorder patients, never administer folate alone before checking B12 (which resolves anemia while accelerating subacute combined degeneration of dorsal columns and lateral corticospinal tracts), and always administer Thiamine (B1) before IV glucose to prevent precipitating Wernicke encephalopathy.